ScholarIQanswers from OpenAlex
Hospital Universitario Puerta de Hierro Majadahonda
InstitutionResearch output, impact & collaborations
Hospital Universitario Puerta de Hierro Majadahonda is a institution indexed in ScholarIQ from OpenAlex.
What is known about Hospital Universitario Puerta de Hierro Majadahonda?
ScholarIQrecord summary
Hospital Universitario Puerta de Hierro Majadahonda is a research organisation in Madrid, ES. OpenAlex records 15,574 works and 769,572 citations for it. 5,056 researchers list it as their most recent affiliation.
How many works does Hospital Universitario Puerta de Hierro Majadahonda have?
ScholarIQindexed works
Hospital Universitario Puerta de Hierro Majadahonda has 15,574 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hospital Universitario Puerta de Hierro Majadahonda have?
ScholarIQcitation count
Hospital Universitario Puerta de Hierro Majadahonda has 769,572 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Hospital Universitario Puerta de Hierro Majadahonda?
ScholarIQresearcher count
Hospital Universitario Puerta de Hierro Majadahonda has 5,056 researchers in the ScholarIQ index.
What is the average h-index at Hospital Universitario Puerta de Hierro Majadahonda?
ScholarIQavg h-index
Hospital Universitario Puerta de Hierro Majadahonda has an average h-index of 55 in OpenAlex.
What is the ROR of Hospital Universitario Puerta de Hierro Majadahonda?
ScholarIQror
The ROR for Hospital Universitario Puerta de Hierro Majadahonda is on the source record.
What is the OpenAlex record for Hospital Universitario Puerta de Hierro Majadahonda?
ScholarIQopenalex
The OpenAlex for Hospital Universitario Puerta de Hierro Majadahonda is on the source record.
Who are the most-cited researchers behind Hospital Universitario Puerta de Hierro Majadahonda?
ScholarIQtop researchers by citations
What are the most-cited papers on Hospital Universitario Puerta de Hierro Majadahonda?
ScholarIQmost cited works
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan Jagasia, Hildegard Greinix, Mukta Arora, Kirsten M. Williams, Daniel Wolff, Edward W. Cowen, Jeanne Palmer, Daniel J. Weisdorf, Nathaniel S. Treister, Guang‐Shing Cheng, Holly Kerr, Pamela Stratton, Rafael F. Duarte, George B. McDonald, Yoshihiro Inamoto, Afonso Celso Vigorito, Sally Arai, Manuel B. Datiles, David A. Jacobsohn, Theo Heller, Carrie L. Kitko, Sandra A. Mitchell, Paul J. Martin, Howard M. Shulman, Roy S. Wu, Corey Cutler, Georgia B. Vogelsang, Stephanie J. Lee, Steven Z. Pavletic, Mary E.D. Flowers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M. Marty, Per Ljungman, Roy F. Chemaly, Johan Maertens, Sanjeet Dadwal, Rafael F. Duarte, Shariq Haider, Andrew J. Ullmann, Yuta Katayama, Janice Brown, Kathleen M. Mullane, Michael Boeckh, Emily A. Blumberg, Hermann Einsele, David R. Snydman, Yoshinobu Kanda, Mark J. DiNubile, Valerie Teal, Hong Wan, Yoshihiko Murata, Nicholas A. Kartsonis, Randi Y. Leavitt, Cyrus Badshah
Perioperative Nivolumab in Resectable Lung Cancer
Tina Cascone, Mark M. Awad, Jonathan Spicer, Jie He, Shun Lü, Boris Sepesi, Fumihiro Tanaka, Janis M. Taube, Robin Cornelissen, Libor Havel, Nina Karaseva, Jarosław Kużdżał, Luboš Petruželka, Lin Wu, Jean-Louis Pujol, Hiroyuki Ito, Tudor–Eliade Ciuleanu, Ludmila de Oliveira Muniz Koch, Annelies Janssens, Aurelia Alexandru, Sabine Bohnet, Fedor V. Moiseyenko, Yang Gao, Yasutaka Watanabe, Cinthya Coronado Erdmann, Padma Sathyanarayana, S. Meadows–Shropshire, Steven I. Blum, Mariano Provencio
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy J. Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Tae Kim, Fernando López‐Ríos, Shun Lü, Tetsuya Mitsudomi, André Moreira, Noriko Motoi, Andrew G. Nicholson, Ricardo Oliveira, Mauro Papotti, Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe
How much of the research on Hospital Universitario Puerta de Hierro Majadahonda is open access?
ScholarIQopen access share
83%OPEN ACCESS